Haemonetics to set up facility in Penang
Haemonetics, a leader in blood-management solutions, is building a world-class facility for manufacturing whole blood and apheresis devices, in which a constituent of blood is separated, in Penang, the Malaysian Biotechnology Corporation (BiotechCorp) ann
The US-based company said that Malaysia offered it proximity to customers in its fastest growing markets, as well as to a number of key suppliers and medical equipment manufacturers.
“Much of our revenue growth is coming from emerging markets and the selection of Penang, Malaysia, for our manufacturing site brings us closer to our customers in the region. It makes for much leaner, more efficient operations,” said David Helsel, Haemonetics executive vice president of global manufacturing.
